Women with breast cancer who take the antidepressant paroxetine at the same time as tamoxifen are at an increased risk of death, concludes a study published on bmj.com today.
See the rest here:
Breast cancer patients taking antidepressant paroxetine at the same time as tamoxifen are at increased risk of death (News-Medical-Net)
Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines.
See more here:
Penn Medicine News: Beating Breast Cancer Drug Side Effects (University of Pennsylvania Health System)
In news that reverses decades of advice given to breast cancer patients, new University of Pennsylvania School of Medicine research reveals that survivors who lift weights are less likely than their non-weightlifting peers to experience worsening symptoms of lymphedema, the arm- and hand-swelling condition that plagues many women following surgery and radiation for their disease.
Go here to read the rest:
Penn Medicine News: Pumping Iron Reduces Arm Swelling and Boosts Self-Esteem After Breast Cancer (University of Pennsylvania Health System)
Circulating metastatic breast cancer cells can lose their epithelial receptors, a process that enables them to travel through the bloodstream undetected, according to research from The University of Texas M. D. Anderson Cancer Center.The findings were presented Dec.
See original here:
Novel Detection Method Unmasks Circulating Breast Cancer Cells (redOrbit)
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.Patients using Herceptin and chemotherapy at the same time had a relative 25 percent reduction in the risk of recurrence of …
See more here:
Breast Cancer Survival Improves Herceptin Used With Chemotherapy (redOrbit)
